Literature DB >> 2123604

Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status.

F Fernández-Bañares1, M D Mingorance, M Esteve, E Cabré, M Lachica, A Abad-Lacruz, A Gil, P Humbert, J Boix, M A Gassull.   

Abstract

Serum levels of zinc, copper, and selenium, and alkaline phosphatase activity were prospectively studied in 29 patients with inflammatory bowel disease. Fifteen patients had extensive active colitis (active colitis group). Seven patients had active, and seven cases inactive small bowel or ileocecal Crohn's disease (small bowel disease group). Ninety-three healthy subjects acted as controls. Serum trace element levels were considered in relation to vitamin A and E levels, nutritional parameters, the activity of the disease, and the recent intake of steroids. The effect of total enteral nutrition on serum trace elements was studied in seven cases. Serum zinc levels were lower and serum copper levels higher in the active colitis group than in controls (p = 0.0007, and p = 0.02, respectively). More than 50% of patients with active colonic or small bowel disease showed zinc levels below the 15th percentile of the control group. Serum zinc levels correlated with plasma vitamin A in acute colitis (r = 0.67; p = 0.006), and with both serum albumin concentration (r = 0.76; p = 0.002) and disease activity score (r = -0.67, p = 0.009) in patients with small bowel disease. The copper:zinc ratio was higher in the active colitis group than in controls (p = 0.002). In spite of the increase in serum albumin levels and the decrease in disease activity, serum zinc levels remained low after total enteral nutrition. The implications of the abnormal trace element status in patients with inflammatory bowel disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123604

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients.

Authors:  Altug Cincin; Murat Sunbul; Tarık Kivrak; Halil Atas; Ibrahim Sari; Kursat Tigen; Tarik Kani; Hakan Akin; Nese Imeryuz; Yelda Basaran
Journal:  Dig Dis Sci       Date:  2014-07-15       Impact factor: 3.199

2.  Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.

Authors:  M Esteve-Comas; M C Núñez; F Fernández-Bañares; A Abad-Lacruz; A Gil; E Cabré; F González-Huix; X Bertrán; M A Gassull
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

3.  A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Authors:  Valérie Marcil; Emile Levy; Devendra Amre; Alain Bitton; Ana Maria Guilhon de Araújo Sant'Anna; Andrew Szilagy; Daniel Sinnett; Ernest G Seidman
Journal:  Inflamm Bowel Dis       Date:  2019-07-17       Impact factor: 5.325

4.  The Copper/Zinc Ratio Correlates With Markers of Disease Activity in Patients With Inflammatory Bowel Disease.

Authors:  Tobias Schneider; Daniel Caviezel; C Korcan Ayata; Caroline Kiss; Jan Hendrik Niess; Petr Hruz
Journal:  Crohns Colitis 360       Date:  2020-01-23

5.  Serum concentrations of trace elements in patients with Crohn's disease receiving enteral nutrition.

Authors:  Tomoko Johtatsu; Akira Andoh; Mika Kurihara; Hiromi Iwakawa; Tomoyuki Tsujikawa; Atsunori Kashiwagi; Yoshihide Fujiyama; Masaya Sasaki
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

6.  Intestinal inflammation in rats induces metallothionein in colonic submucosa.

Authors:  Yasmin Al-Gindan; Mohammed Shawarby; Amy Noto; Carla G Taylor
Journal:  J Clin Biochem Nutr       Date:  2009-02-28       Impact factor: 3.114

7.  A STROBE compliant observational study on trace elements in patients with ulcerative colitis and their relationship with disease activity.

Authors:  Farid Poursadegh; Mitra Ahadi; Hassan Vosoughinia; Maryam Salehi; Ali Beheshti Namdar; Mohammad Reza Farzanehfar; Bahram Memar; Reza Ziaolhagh
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.